SCHEMBL8512448

SCHEMBL8512448

CCOC(=O)c1c(-c2ccc(-c3ccc(OC(F)(F)F)cc3)cc2)[nH]c2ccccc2c1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.50
MEN1 O00255 5/20 0.50
ALDH1A1 P00352 4/20 0.50
LMNA P02545 4/20 0.50
MAPT P10636 4/20 0.50
KDM4E B2RXH2 3/20 0.50
HSD17B10 Q99714 2/20 0.50
NPC1 O15118 1/20 0.50
GAA P10253 1/20 0.50
HPGD P15428 1/20 0.50
MAPK10 P53779 1/20 0.50
ALOX5 P09917 3/20 0.46
PTGES O14684 2/20 0.46
ADORA3 P0DMS8 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
HCRTR1 O43613 1/20 0.44
RAB9A P51151 1/20 0.44
TSHR P16473 2/20 0.43
AKT1 P31749 1/20 0.43
TDP1 Q9NUW8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8512623 0.94 NPC1 (0.47) KMT2AMEN1ALDH1A1LMNAMAPT
SCHEMBL9607469 0.88 MAT2A (0.44) KMT2AMEN1ALDH1A1LMNAMAPT
SCHEMBL8613034 0.85 KIF11 (0.47) MAPTKDM4ETDP1
SCHEMBL6300719 0.84 ALDH1A1 (0.67) KMT2AMEN1ALDH1A1LMNAMAPT
SCHEMBL8515925 0.84 ALOX5 (0.64) KMT2AMEN1ALDH1A1LMNAMAPT
SCHEMBL8512850 0.83 MEN1 (0.56) KMT2AMEN1ALDH1A1LMNAMAPT
SCHEMBL8537027 0.83 ALDH1A1 (0.41) KMT2AMEN1ALDH1A1LMNAMAPT
SCHEMBL8512624 0.83 ALOX5 (0.50) ALOX5PTGES
SCHEMBL8515371 0.82 MAT2A (0.56) KMT2AALDH1A1LMNAMAPTKDM4E
SCHEMBL8514142 0.81 ALOX5 (0.48) ALOX5PTGES

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10799494-B2 Combination of respiratory electron transport chain inhibitors with a cytochrome bd inhibitor LIVERPOOL SCHOOL TROPICAL MEDICINE (GB) 2020-10-13 US claimed
US-20190151305-A1 COMBINATION PRODUCT LIVERPOOL SCHOOL TROPICAL MEDICINE (GB) 2019-05-23 US claimed
US-10799494-B2 Combination of respiratory electron transport chain inhibitors with a cytochrome bd inhibitor LIVERPOOL SCHOOL TROPICAL MEDICINE (GB) 2020-10-13 US disclosed
US-10799494-B2 Combination of respiratory electron transport chain inhibitors with a cytochrome bd inhibitor LIVERPOOL SCHOOL TROPICAL MEDICINE (GB) 2020-10-13 US disclosed
US-20190151305-A1 COMBINATION PRODUCT LIVERPOOL SCHOOL TROPICAL MEDICINE (GB) 2019-05-23 US disclosed
US-20190151305-A1 COMBINATION PRODUCT LIVERPOOL SCHOOL TROPICAL MEDICINE (GB) 2019-05-23 US disclosed
WO-2012069856-A1 ANTIMALARIAL COMPOUNDS LIVERPOOL SCHOOL OF TROPICAL MEDICINE (GB) 2012-05-31 WO disclosed
WO-2012069856-A1 ANTIMALARIAL COMPOUNDS LIVERPOOL SCHOOL OF TROPICAL MEDICINE (GB) 2012-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10799494-B2 Combination of respiratory electron transport chain inhibitors with a cytochrome bd inhibitor NDUFB7, NDUFB3, NDUFB5 KMT2A 4537/4885MEN1 4848/4885ALDH1A1 846/4885
US-20190151305-A1 COMBINATION PRODUCT NDUFB5, NDUFB7, NDUFB10 KMT2A 4668/4885MEN1 4581/4885ALDH1A1 857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.